RecruitingNCT03398629

Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies

Diagnosis and Management of Intrauterine Growth Restriction, Structural Anomalies and Chromosomal Anomalies: A Prospective Cohort Study


Sponsor

Guangzhou Women and Children's Medical Center

Enrollment

10,000 participants

Start Date

May 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this prospective cohort study is to build a large platform that includes clinical information (prenatal diagnosis and postnatal follow-up data) and biological specimen banks of fetuses/infants with IUGR or congenital anomalies, which provide vital support and research foundation for accurate diagnosis, precision treatment and meticulous management.


Eligibility

Max Age: 18 Years

Inclusion Criteria4

  • All pregnant women who present to Guangzhou Women and Children's Medical Center meeting one of the following prenatal diagnoses and neonates/infants who are diagnosed as one of the following anomalies will be invited to participate:
  • Intrauterine growth restriction (IUGR)
  • Structural anomaly
  • Chromosomal anomaly

Exclusion Criteria3

  • Pregnant women who don't agree to participate;
  • Pregnant women delivering babies at other hospitals.
  • Prenatally suspected anomalies that are not confirmed by postnatal diagnosis.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Guangzhou Women and Children's Medical Center

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03398629


Related Trials